OPTN/SRTR 2023 Annual Data Report: Intestine

IF 8.9 2区 医学 Q1 SURGERY American Journal of Transplantation Pub Date : 2025-02-01 DOI:10.1016/j.ajt.2025.01.023
Simon P. Horslen , Vikram K. Raghu , Yoon Son Ahn , Jesse Howell , Benjamin Schumacher , Meghan McDermott , Ajay K. Israni , Jon J. Snyder
{"title":"OPTN/SRTR 2023 Annual Data Report: Intestine","authors":"Simon P. Horslen ,&nbsp;Vikram K. Raghu ,&nbsp;Yoon Son Ahn ,&nbsp;Jesse Howell ,&nbsp;Benjamin Schumacher ,&nbsp;Meghan McDermott ,&nbsp;Ajay K. Israni ,&nbsp;Jon J. Snyder","doi":"10.1016/j.ajt.2025.01.023","DOIUrl":null,"url":null,"abstract":"<div><div>Intestine transplant can have significant health and quality-of-life benefits for those who require it. Despite its infrequent use, intestine transplant remains a mainstay of treating those with complications from long-term parenteral nutrition due to intestinal failure, as well as salvage therapy for those with a significant abdominal catastrophe. In 2023, there were 135 candidates added to the intestine transplant waiting list. Those awaiting intestine-without-liver transplant have low mortality on the waiting list, with no reported deaths in 2023. However, 8 patients died awaiting intestine-with-liver transplant, and the estimated 3-year mortality for those listed exceeds 10.0%. A total of 95 intestine transplants were performed in 2023, with only 33 performed in the pediatric age range. However, 18 of 34 recipients of intestine-with-liver transplant were in the pediatric age range. Immunosuppression for intestine transplants most commonly included an induction agent followed by maintenance with a combination of medications that included tacrolimus. In the recipients of intestine-without-liver transplants, 1- and 5-year graft survival were 78.3% and 46.5% in adult and 76.1% and 52.2% in pediatric recipients, respectively. In the recipients of intestine-with-liver transplants, 1- and 5-year graft survival were 57.8% and 45.6% in adult and 81.1% and 60.0% in pediatric recipients, respectively. Acute rejection episodes occurred for approximately 20.0% of patients within the first year. The 5-year cumulative incidence of posttransplant lymphoproliferative disorder was higher in those with an intestine-without-liver transplant (11.5%) compared with those who also received a liver (2.5%). Rates of intestine transplant have remained stable for the past several years, with increasing need in the adult population. Future reports may reflect whether children who have avoided intestine transplant with the recent advances in intestinal rehabilitation ultimately require the procedure in adulthood.</div></div>","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"25 2","pages":"Pages S288-S328"},"PeriodicalIF":8.9000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Transplantation","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1600613525000292","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Intestine transplant can have significant health and quality-of-life benefits for those who require it. Despite its infrequent use, intestine transplant remains a mainstay of treating those with complications from long-term parenteral nutrition due to intestinal failure, as well as salvage therapy for those with a significant abdominal catastrophe. In 2023, there were 135 candidates added to the intestine transplant waiting list. Those awaiting intestine-without-liver transplant have low mortality on the waiting list, with no reported deaths in 2023. However, 8 patients died awaiting intestine-with-liver transplant, and the estimated 3-year mortality for those listed exceeds 10.0%. A total of 95 intestine transplants were performed in 2023, with only 33 performed in the pediatric age range. However, 18 of 34 recipients of intestine-with-liver transplant were in the pediatric age range. Immunosuppression for intestine transplants most commonly included an induction agent followed by maintenance with a combination of medications that included tacrolimus. In the recipients of intestine-without-liver transplants, 1- and 5-year graft survival were 78.3% and 46.5% in adult and 76.1% and 52.2% in pediatric recipients, respectively. In the recipients of intestine-with-liver transplants, 1- and 5-year graft survival were 57.8% and 45.6% in adult and 81.1% and 60.0% in pediatric recipients, respectively. Acute rejection episodes occurred for approximately 20.0% of patients within the first year. The 5-year cumulative incidence of posttransplant lymphoproliferative disorder was higher in those with an intestine-without-liver transplant (11.5%) compared with those who also received a liver (2.5%). Rates of intestine transplant have remained stable for the past several years, with increasing need in the adult population. Future reports may reflect whether children who have avoided intestine transplant with the recent advances in intestinal rehabilitation ultimately require the procedure in adulthood.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
18.70
自引率
4.50%
发文量
346
审稿时长
26 days
期刊介绍: The American Journal of Transplantation is a leading journal in the field of transplantation. It serves as a forum for debate and reassessment, an agent of change, and a major platform for promoting understanding, improving results, and advancing science. Published monthly, it provides an essential resource for researchers and clinicians worldwide. The journal publishes original articles, case reports, invited reviews, letters to the editor, critical reviews, news features, consensus documents, and guidelines over 12 issues a year. It covers all major subject areas in transplantation, including thoracic (heart, lung), abdominal (kidney, liver, pancreas, islets), tissue and stem cell transplantation, organ and tissue donation and preservation, tissue injury, repair, inflammation, and aging, histocompatibility, drugs and pharmacology, graft survival, and prevention of graft dysfunction and failure. It also explores ethical and social issues in the field.
期刊最新文献
Outside Front Cover Gut microbiome alterations precede graft rejection in kidney transplantation patients. Perioperative C1-esterase inhibitor therapy to allow transplantation in a highly sensitized lung transplant candidate: three case reports. Association between out of sequence allocation and deceased donor kidney non-utilization across Organ Procurement Organizations. Longer Travel and Traffic are Associated with Adult Liver Transplant Waitlist Mortality in the United States.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1